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AbstrAct
background Tuberculosis (TB) is a major cause of death 
in Ethiopia. One of the main barriers for TB control is the 
lack of access to health services.
Methods We evaluated a diagnostic and treatment service 
for TB based on the health extension workers (HEW) of 
the Ethiopian Health Extension Programme in Sidama 
Zone, with 3.5 million population. We added the services 
to the HEW routines and evaluated their effect over 4.5 
years. 1024 HEWs were trained to identify individuals 
with symptoms of TB, request sputum samples and 
prepare smears. Smears were transported to designated 
laboratories. Individuals with TB were offered treatment 
at home or the local health post. A second zone (Hadiya) 
with 1.2 million population was selected as control. We 
compared TB case notification rates (CNR) and treatment 
outcomes in the zones 3 years before and 4.5 years after 
intervention.
results HEWs identified 216 165 individuals with symptoms 
and 27 918 (12%) were diagnosed with TB. Smear-positive TB 
CNR increased from 64 (95% CI 62.5 to 65.8) to 127 (95% CI 
123.8 to 131.2) and all forms of TB increased from 102 (95% 
CI 99.1 to 105.8) to 177 (95% CI 172.6 to 181.0) per 100 000 
population in the first year of intervention. In subsequent 
years, the smear-positive CNR declined by 9% per year. There 
was no change in CNR in the control area. Treatment success 
increased from 76% before the intervention to 95% during the 
intervention. Patients lost to follow-up decreased from 21% to 
3% (p<0.001).
conclusion A community-based package significantly 
increased case finding and improved treatment outcome. 
Implementing this strategy could help meet the Ethiopian 
Sustainable Development Goal targets.
IntroductIon
Tuberculosis (TB) is a leading cause of death 
among infectious diseases and is responsible 
for 1.8 million deaths each year.1 Over 4 million 
incident cases of TB worldwide fail to be diag-
nosed or linked into TB services every year1 
and people with undetected TB have a high 
mortality and perpetuate disease transmission. 
Identifying and treating these individuals is 
crucial.
Although TB incidence has been declining 
since 2002, this decline has been slow, only 
achieving a reduction of <2% per year and 
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Key questions
What is already known about this topic?
 ► Tuberculosis disproportionally affects poor 
populations in urban slums and rural areas.
 ► Access to tuberculosis diagnostic and treatment 
services is a major barrier for these populations.
 ► An estimated 4.5 million individuals with 
tuberculosis do not reach the health services each 
year.
 ► Finding these ‘missing’ cases is an international 
priority for tuberculosis control.
What are the new findings?
 ► Female community health workers providing 
services for the diagnosis and treatment of 
tuberculosis at village level significantly increase 
the number of cases diagnosed in the rural areas.
 ► The proportion of women screened in this service 
was higher than in the health centres.
 ► The service increased the proportion of 
individuals who completed treatment, reaching an 
unprecedented 95%.
 ► The proportion of patients lost to follow-up 
decreased to an unprecedented low level.
 ► After an initial peak in the number of cases, the 
case notification rate declined from this peak by 9% 
per year, suggesting a decline in transmission.
recommendations for policy
 ► The study confirms that there is a large pool of 
individuals with tuberculosis who do not access 
health services.
 ► Countries attempting to increase the detection of 
tuberculosis in rural areas need to consider that the 
poor accessibility of services is a major barrier for 
tuberculosis diagnosis and treatment.
 ► The provision of services at community level 
increases case detection, treatment acceptance 
and treatment completion.
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Figure 1 Map of the implementation (Sidama) and control 
(Hadiya) zones.
Box summary of the intervention package implemented 
in sidama Zone
1. Capacity strengthening: training for health workers, HEWs and 
laboratory staff; provision of LED fluorescent microscopes to high-
volume microscopy centres and GeneXpert for two centres.
2. Continuous advocacy, communication and social mobilisation 
(ACSM).
3. Fortnightly house-to-house visits by HEWs to identify residents 
with chronic cough, inform them how to produce sputum and 
prepare smears for smear microscopy. Xpert testing for children, 
HIV-positive individuals and patients who continued to be 
symptomatic after two smear-negative results.
4. Provision of communication facilities and transport. HEWs 
and project supervisors received airtime credits to facilitate 
communication. Supervisors had motorbikes to link the HEWs to 
TB diagnostic and treatment services.
5. Supervisors transported smears to microscopy centres, 
communicated test results, registered patients by proxy at 
health centres to release treatment and initiated treatment in the 
community. Patients chose to receive the treatment at home or at 
the kebele health post staffed by the HEWs.
6. HEWs and supervisors screened household contacts to identify 
and investigate symptomatic individuals, and to provide IPT for 
children, and followed people with smear-negative results.
HEW, health extension worker; IPT, isoniazid preventative therapy; LED, light-
emitting diode; TB, tuberculosis.
achieving the Sustainable Development Goals of ending 
the TB epidemic in 20302 will require a paradigm shift 
in how we address TB. This would require concerted 
efforts and investment into innovative high-impact inter-
ventions that reach all populations and eliminate the 
barriers to access services.3 TB programmes have histor-
ically followed passive case finding approaches in which 
services wait for individuals with symptoms to visit health 
facilities,4 5 but symptoms of TB are non-specific and trav-
elling to health facilities is costly and difficult in many 
settings, particularly in rural areas.6 7
Ethiopia has the third highest burden of TB cases in 
Africa with an estimated incidence of 207 cases (all forms) 
of TB per 100 000 population. Despite a major expansion 
and decentralisation of diagnostic and treatment centres, 
the case detection is still 74% and it is estimated that the 
health system misses about 50 000 people with incident 
TB each year.8
Ethiopia however is a country that is making consid-
erable progress in improving its health system, which is 
partly due to the government launching the Ethiopian 
Health Extension Programme (HEP) in 2003 to increase 
population access to basic health services. The HEP trains 
and employs female village-based health workers, called 
health extension workers (HEW), to regularly visit house-
holds in their villages (called kebeles) to implement basic 
packages of healthcare. For this study, we added a diag-
nostic and treatment service for TB to their packages of 
service and evaluated the effects on a large-scale and over 
a long duration.
MetHods
This was a community-based intervention based in 
Sidama Zone, in the Southern Nations, Nationalities, 
and Peoples’ Region (SNNPR) of Ethiopia. Sidama 
has 524 rural and 39 urban kebeles with a popula-
tion of 3.5 million. Kebeles or villages are the smallest 
administrative unit of the country and have approxi-
mately 5000 population. The zone covers an area of 
10 000 km2 and the population is dispersed (figure 1). 
Transport facilities are limited and relatively expensive, 
making travel to health facilities challenging. All kebeles 
in Sidama were included in our study.
The intervention consisted of engaging the HEWs 
of the Ethiopian HEP and facilitating their linkage to 
laboratory services and treatment through a transport 
network using motorbikes and was implemented in part-
nership with the Sidama Zone Health Department and 
the SNNPR Health Bureau. Before the intervention, 
HEWs were expected to visit all the households in their 
kebeles fortnightly, to provide education for TB, coun-
selling on treatment adherence and referred persons 
with presumptive TB to the health centres. However, few 
patients were identified and the uptake of referral was 
very low.
The intervention package is summarised in box and was 
described in detail in a previous publication9 (figure 2). 
In brief, all 1024 HEWs of the HEP in Sidama were 
trained by project and TB Programme staff in 5-day work-
shops to identify household members with symptoms 
suggestive of TB (mostly by asking if there were residents 
with persistent cough), request one sputum sample from 
symptomatic persons and learn how to prepare smears 
in the local health post. Smears were then transported 
from the village to a designated laboratory on motorbike 
by a HEW supervisor. Smears were examined using light 
smear microscopy. Persons with smear-positive TB were 
Datiko DG, et al. BMJ Glob Health 2017;2:e000390. doi:10.1136/bmjgh-2017-000390 3
BMJ Global Health
Figure 2 Schematic representation of the intervention package and the current passive case finding approach. ACSM, 
advocacy, communication and social mobilisation; HEW, health extension worker; IPT, isoniazid preventative therapy; LED-FM, 
light-emitting diode fluorescence microscopy.
visited at home by the field supervisor and offered initi-
ation of anti-TB treatment. Treatment could be received 
in the home or at the local health post. Other household 
members were then screened for TB-associated symp-
toms and children under 5 years without symptoms were 
offered isoniazid preventive therapy for 6 months. The 
HEWs subsequently provided adherence support for the 
duration of treatment.
As part of the strengthening of the TB laboratories in 
preparation for the project, 19 light-emitting diode micro-
scopes and two 4-module GeneXpert machines were 
installed in the diagnostic centres serving the area.
A second zone (Hadiya) with similar characteristics but 
no geographical connection to Sidama was selected as a 
control area. Hadiya has a population of about 1.2 million 
over an area of 3593.31 km2, has similar density of health 
facilities and treatment services, and has similar socio-eco-
nomic indicators. This zone was selected because it was 
considered to resemble the characteristics of the inter-
vention area.
Individuals with TB identified by the HEWs in the 
intervention area were registered by proxy by the super-
visors in the TB treatment centres nearest to their kebele. 
Data on the number of TB cases identified by the HEWs 
and of those self-referring to diagnostic and treatment 
centres were collected prospectively by the field supervi-
sors on paper case-record forms. Data from the control 
zone were collected from the routine surveillance quar-
terly reports and used for secondary data analysis. Only 
data essential to health services were collected.
TB surveillance and cohort data for Sidama and 
Hadiya Zones were collected for the 3 years preceding 
the intervention to establish baseline trends. The quality 
of the surveillance reports was examined by collecting 
the data from the original health centre TB registers 
and comparing the tallies produced by the project staff 
with those produced routinely and discrepancies or data 
duplication were corrected. Health facilities in Sidama 
(the intervention zone) had tested 12 800 symptom-
atic individuals for TB with smear microscopy in the 
12 months prior to the intervention (1067/month). Of 
these, 2534 (19.8%) were new smear-positive and 3968 
all forms of TB (means 211 and 330 cases/month, respec-
tively), resulting in a case notification rate (CNR) of 64 
smear-positive and 100 all forms of TB cases per 100 000 
population per year prior to intervention. The preinter-
vention baseline male:female ratio of smear-positive cases 
was 1.3:1. The treatment success rate (TSR) was 76%, with 
21% of persons who started anti-TB treatment being lost 
to follow-up (LTFU). Health facilities in the control zone 
(Hadiya) notified 949 smear-positive and 2497 all forms of 
TB cases (79 and 208 cases/month, respectively) during 
the same period, resulting in smear-positive and all forms 
of TB CNRs of 67 and 177 per 100 000 population, respec-
tively. The TSR was 82%, with 16% being LTFU. Prospec-
tive TB surveillance and cohort data for Sidama were 
then collected using the same forms. All patients identi-
fied by the HEWs were registered by the health extension 
supervisors at the nearest health centre providing TB 
treatment. HEW supervisors also maintained a duplicate 
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Figure 3 Number of tuberculosis (TB) cases (all forms and bacteriologically positive (Bact+)) detected before and during the 
intervention in the intervention and control zones. The arrows denote the start of the intervention.
TB register to be able to classify patients identified by the 
intervention and those who attended the health centres. 
Prospective quarterly reports were also checked for data 
errors and duplication.
statistical analysis
All data were entered into a dedicated database and 
analysed using SPSS Version 11. Impact was assessed by 
comparing the annual number of cases detected and 
treatment outcomes before and after implementation 
and between the intervention and control zones. Trends 
in case notifications were calculated before and after the 
intervention and the reduction in the number of cases 
was calculated using the first year of the intervention 
as the baseline. Descriptive data were analysed using 
summary statistics and 95% CIs. χ2tests were used to test 
differences in proportions over the study period. Contin-
uous variables with normal distributions were compared 
using means and SD and tested using parametric statis-
tics. p Values <0.05 were considered statistically signifi-
cant.
ethical considerations
Support for the implementation of the project was 
obtained from the Ministry of Health of Ethiopia and the 
Southern Region Health Bureau.
results
Identification of symptomatic individuals and diagnosis of tb
A total of 216 174 (mean 4,003/month) individuals with 
TB symptoms were identified by the HEWs and a total 
of 27 918 TB cases were registered over the 4.5 interven-
tion years in Sidama Zone. This was equivalent to a mean 
of 517 TB cases per month, which was higher than the 
mean of 330 TB cases per month in the baseline period 
(p<0.001). Among the 27 918 TB cases, 27 468 (95.2%) 
were new and 1352 (4.8%) retreatment cases.
Sixty-one per cent (16 895/27 468) of the TB cases in 
the intervention period were smear positive compared 
with 38% (2534/6502) in the baseline period, with the 
number of smear-positive cases increasing from a mean 
of 211 cases per month in the baseline to 312 cases/
month in the intervention period (figure 3). In total, 
11 130 (66%) of 16 895 smear-positive cases were identi-
fied by the HEWs through door-to-door visits and 5765 
(34%) by the health centres. A further 2578 (1.3%) 
village participants with smear-negative results received 
financial support to travel to the clinics to have X-ray 
examinations. Of these, 1730 (67.1%) were diagnosed as 
having smear-negative TB based on radiological patterns. 
X-rays therefore contributed to 6% of the TB cases noti-
fied by the HEWs in the intervention zone.
The smear-positive CNR increased from a baseline of 
64 (95% CI 62.5 to 65.8) to 127 (95% CI 123.8 to 131.2) 
per 100 000 population at the start of the intervention 
and all forms of TB increased from 102 (95% CI 99.1 to 
105.8) to 177 (95% CI 172.6 to 181.0) per 100 000 popu-
lation, respectively. There was a peak smear-positive CNR 
(129 per 100 000 population) in the second quarter of 
the first year of the intervention. The CNR stayed above 
the baseline after this peak but declined steadily to 80 
cases per 100 000 population by the end of the inter-
vention (a decline of 9% per year, p<0.01), as shown 
in figure 3. Likewise, all forms of TB CNR reached 264 
per 100 000 in the second year of the intervention and 
declined to 167 (a decline of 37%) by the end of the 
study (p<0.01).
In comparison, Hadiya reported 2551 smear-positive 
and 5483 all forms of TB cases during the first 2.5 years 
when the intervention was implemented in Sidama, 
resulting in 86 smear-positive and 185 all forms of TB 
per 100 000 population per year, which was similar to the 
baseline (p>0.1).
Identification of further cases among household contacts
A total of 8748 (79%) of the 11 130 smear-positive 
TB cases diagnosed through the HEWs were visited 
again by the HEW and supervisors to identify house-
hold contacts. The visits identified 38 534 household 
contacts, of whom 5737 (14.9%) had symptoms sugges-
tive of TB. Of these, 4520 (78.8%) produced sputum 
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for examination, resulting in 288 (6.4%) additional 
smear-positive cases.
Age and gender distribution of patients
Fifty-eight per cent (125 376) of the 216 174 individ-
uals with symptoms of TB identified by the HEWs were 
female and 90 798 (42%) were male. Women were less 
likely to be smear positive than men (4% vs 6%) but their 
larger number resulted in a higher number confirmed 
to be smear positive (5899 (53%) female vs 5213 (47%) 
male, p<0.001). The proportion of male-to-female cases 
changed from 1.3:1 before the intervention to 1:1 during 
the intervention.
The mean (SD) age of TB cases was 30 (17) years, 
with 1215 (8%) being <15. Male cases were older than 
female cases (mean (SD) 31 (16) and 29 (14), respectively, 
p<0.001). The number of smear-positive, smear-negative 
and extrapulmonary TB cases by age during the inter-
vention period is shown in table 1. As expected, most 
TB cases <5 years old were classified as smear-negative or 
extrapulmonary TB. The proportion of cases classified 
as smear positive decreased from 65% in 2010 (779 out 
of 1198 cases) to 50% (868 out of 1747) in 2015 (χ2 for 
trend, p<0.01).
treatment outcome
Treatment outcome was known for 20 108 registered 
patients in the intervention zone at the time of anal-
ysis. The TSR for all forms of TB was 76% before the 
intervention (2358/3110) and 95% (19 003/20 108) 
during the intervention (p<0.001), as shown in table 2. 
Women had similar treatment outcome as men (95% 
vs 94% for men). Treatment success was highest among 
patients 15–35 years old and then declined slightly. 
Children aged <5 years and patients aged >65 years had 
relatively low TSRs (91% and 89%, respectively) than 
5–64 year-old patients (p=0.02 and p<0.001, respectively) 
as shown in figure 4. The proportion of patients LTFU 
decreased from 651/3110 (21%, 95% CI 19.5% to 22.4%) 
before the intervention to 598/20 108 (3%, 95% CI 2.7% 
to 3.2%) after the intervention (p<0.001).
dIscussIon
Our results achieved over a 4.5-year time span demon-
strate that basic diagnostic and treatment support TB 
services added to the workload of community health 
workers visiting households door-to-door as part of 
routine health support can dramatically increase the 
number of TB cases detected and improve uptake and 
completion of treatment to over 95%. Moreover, these 
effects occur rapidly, within a year of implementation, 
and they can be sustained on a large scale and over a 
long term.
These results demonstrate that initiatives and tools 
that address barriers to access diagnosis have enormous 
potential to improve stagnating case detection rates and 
could play a significant role to meet the targets of the 
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Table 2 Treatment outcome of cohorts registered 1 year prior to the project period and during the implementation period
Category
Treatment outcome, n (%)
Cured Completed
Treatment 
success Died Failure
Lost to follow-
up* Registered
Baseline period
  New TB cases 810 1429 2239 (76) 80 (2.7) 8 (0.3) 608 (21) 2935
  Retreatment cases 56 63 119 (68) 13 (7) 0 43 (25) 175
  Total 866 1492 2358 (76) 93 (3) 80 (3) 651 (21) 3110
Intervention period
  New TB cases 11 574 7044 18 618 (95) 450 (2) 38 (0.2) 578 (3) 19 684
  Retreatment cases 243 142 385 (91) 14 (3) 5 (1) 20 (5) 424
  Total 11 817 7186 19 003 (95) 464 (2) 43 (0.2) 598 (3) 20 108
*Includes those patients whose treatment outcome was not available, transferred out, or not evaluated.
TB, tuberculosis.
Figure 4 Treatment success rate (cured and treatment 
completed) of patients with new tuberculosis (TB) treated in 
intervention zone by gender and age.
End TB Strategy.2 10 Furthermore, after the initial peak 
of cases, the number of cases declined substantially, with 
a mean CNR reduction of 9% per year, with a staggering 
38% overall reduction in the number of cases between 
the start and the end of the study at 4.5 years. This is 
the first large-scale study of its kind to show dramatic 
increases in TB case detection and the first intervention 
to achieve such high and sustained rates of TB treatment 
success, and together with other smaller studies, add to 
the body of evidence.10
The percentage reduction we achieved is the highest 
reduction reported by any intervention study on the 
continent, approaching the decline rates achieved in 
other countries during the Directly Observed Therapy 
Strategy (DOTS) expansion era,11 12 when there was 
a massive focus placed on enhancing TB control and 
providing consistent diagnostic and treatment services 
for TB. We show that a simple enhancement of routine 
community-based care has a massive effect on top of 
what was achieved by the DOTS expansion. Reductions 
of a magnitude of 10% are needed to achieve the inter-
national targets of reduction in TB incidence by 20352 
and undoubtedly, meeting the targets will require further 
decentralisation, outreach services and a shift in the 
mindset of control programmes.
There are multiple intersecting barriers that limit the 
population’s access to TB services, including low disease 
awareness, stigma, and geographic, gender and socioeco-
nomic barriers.13 14 These barriers are especially prom-
inent among rural areas which often have the weakest 
and most poorly staffed health services and patients 
are too often missed by the way services are currently 
provided.15 16 We have thus demonstrated that bringing 
simple services that detect disease and provide treatment 
support close to where patients live is critical to increase 
access to TB diagnosis and treatment adherence and 
minimise the number of patients LTFU. Indeed, the 
reduction of LTFU from a high 21% before the interven-
tion to a minimal 3% after the intervention is one of the 
major intervention successes, highlighting that cases that 
are LTFU may experience important but unquantified 
barriers accessing services.
Health services should be universal and serve all popu-
lations and ideally new interventions should be inte-
grated within existing health system structures to ensure 
sustainability. Approaches that also facilitate task shifting 
of services to the locations where they are most needed 
can strengthen the ability of the National Tuberculosis 
Programme (NTP) to identify individuals out of reach 
of stationary health services. Similar task shifting has 
successfully been used for malaria and HIV17 and their 
positioning within existing community-based structures 
supports access and facilitates integration into routine 
services.17–19 It is thus likely individuals with other condi-
tions that require access to health services would similarly 
benefit from locally available services that provide acces-
sible diagnosis and treatment at low cost to the patient. 
Our intervention has highlighted the large unmet need 
for services for individuals with undiagnosed TB, but it 
is likely the same situation occurs for other conditions 
such as HIV, diabetes and hypertension. Although HEWs 
used to refer patients with presumptive TB to stationary 
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services as part of the HEP package, the number of indi-
viduals following their advice was minimal and their 
ability to diagnose and treat individuals locally increases 
their efficacy. It is thus likely a multipurpose service that 
brings the diagnosis and treatment close to the popula-
tion would increase the efficacy of the HEP.
It is noticeable that among the 27 918 TB cases diag-
nosed, only 1352 (4.8%) were individuals who had previ-
ously received treatment (retreatment cases). This is a low 
percentage compared with the proportion of retreatment 
cases reported by the health facilities, suggesting that 
individuals were less likely to be diagnosed and receive 
treatment before the services were provided locally by the 
community health workers. We also observed a change 
in the gender distribution of cases from 1.3:1 male-to-
female ratio in the health centres before the interven-
tion to 1:1 during the intervention. This change may 
have resulted from the higher proportion of women 
accessing the service in the villages. While HEWs iden-
tified more female than male patients with TB, health 
centres continued to identify more men than women 
with TB. This could be due to women facing more diffi-
culties accessing health services for TB20 21 or that services 
delivered by female HEWs within the village facilitate 
reaching women more readily than men.22 23
Our findings need to be interpreted within the limitations 
of the study. Although the increased detection and subse-
quent reduction of cases could be due to improved access to 
diagnosis, the identification of a backlog of cases and subse-
quent reduction of transmission, the study design does not 
allow us to establish causality and it could be equally due 
to staff fatigue and poor performance of the programme. 
Its non-randomised and open design is inferior to a 
randomised trial and concurrent interventions in the area 
may have led to confounding and misinterpretation of data. 
The package was also less efficient confirming children, 
as children are rarely able to provide sputum. X-rays and 
Xpert were used by a small proportion of participants but 
this required attending health facilities and further child-
friendly approaches are needed.24–27 Furthermore, the 
package was intentionally comprehensive and integrated 
and it is difficult to single out which components have 
more impact than others. NTP staff however often discuss 
whether some components are more efficient than others 
and want to cherry-pick the cheaper components or those 
perceived to be most important. Finally, despite the signif-
icant improvement in TB treatment outcome, some age 
groups continued to have slightly lower TSRs than others. 
This is especially true for young children and older individ-
uals above 65 years old. There may be further biological and 
social factors that increase the likelihood of unfavourable 
treatment outcome among these age groups.
Our findings demonstrate that high case notification 
and treatment success could be achieved within the 
existing HEP in rural communities of Ethiopia. The 
strength of the intervention was likely due to its embedded-
ness within the existing HEP and the NTP; its partnership 
with a functioning HEW system, strategic engagement 
with stakeholders and its alignment with national health 
policies and priorities. We created evidence to inform 
decision-making and policy changes at national scale and 
the NTP recently included the package in its request for 
funding from the Global Fund. Funds to scale up the 
intervention throughout the country were awarded and 
the intervention is being scaled up to other zones.
In conclusion, the service engaged the community, 
contributed to health system strengthening and provided 
a continuum of care, resulting in significant improve-
ments in both case finding and treatment outcome. A key 
component of the package was its integration with the 
HEP and the NTP which facilitated sustainability. Inter-
ventions that are integrated into existing health systems 
and community-based approaches can contribute to the 
delivery of universal and equitable TB diagnostic and 
treatment services for all populations, including those 
who are vulnerable or disadvantaged. With the onus on 
universal healthcare and the Sustainable Development 
Goals (SDGs) there is increasing interest in communi-
ty-based health systems and community health workers.28 
Country contexts where these are well established29 could 
consider similar approaches, as the availability of a func-
tioning community system would facilitate the imple-
mentation and sustainability of the package.
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